| J9271 | Injection, pembrolizumab, 1 mg | 17,400 | $40 | $748.2K |
| J0897 | Injection, denosumab, 1 mg | 9,600 | $20 | $172.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 850 | $100 | $81K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 370 | $110 | $40.7K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 380 | $90 | $35.7K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17,100 | $1 | $34.2K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 25,500 | $1 | $25.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 170 | $140 | $22.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 100 | $120 | $12.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 200 | $50 | $10.7K |